INTRODUCTION
Skin and its appendages provide a protective barrier essential for animal survival. Hair morphogenesis and epidermal development are orchestrated by an array of cytokines and growth factors (Fuchs and Raghavan, 2002) . Signaling by these diffusible molecules provides spatially and temporally controlled cellular programs for keratinocyte proliferation, differentiation, migration, and finally, terminal differentiation and cornification. TGF-a and epidermal growth factor (EGF) are related autocrine/paracrine growth factors that activate the EGF receptor (EGFR; ErbB1) to regulate the balance between keratinocyte proliferation and differentiation (Schneider et al., 2008) . Defective TGF-a/EGFR signaling leads to abnormal hair morphogenesis, manifested by the ''wavy hair'' and ''curly whiskers'' phenotypes of spontaneous loss-of-function mouse mutations in TGF-a (named waved-1 or wa1) and in EGFR (named waved-2 or wa2), respectively (Ballaro et al., 2005; Luetteke et al., 1993 Luetteke et al., , 1994 Mann et al., 1993; Murillas et al., 1995; Schneider et al., 2008; Sibilia and Wagner, 1995; Threadgill et al., 1995) . Excessive activities of TGF-a/EGFR cause a hairless phenotype and skin cancers (Ferby et al., 2006; Schneider et al., 2008) . The mechanisms by which TGF-a/EGFR signaling determines cell fate (proliferation versus differentiation) of follicular and interfollicular (epidermal) keratinocytes are not completely understood.
Accumulated evidence suggests that both negative and positive feedback mechanisms coexist in the TGF-a/EGFR signaling axis. EGF binding triggers rapid degradation of the EGFR through endocytic pathways but also leads to further production and release/shedding of TGF-a/EGF (Coffey et al., 1987; Peschon et al., 1998) . This unique autoinduction mechanism may contribute to the effects of TGF-a/EGF on keratinocyte terminal differentiation (Peus et al., 1997; Sakai et al., 1994;  ) mice. Whereas more than 80% of WT keratinocytes responded strongly to the V3 agonist cocktail, negligible responses were observed for V3 KO keratinocytes. Positive controls: $60%-80% keratinocytes from both genotypes (WT and V3 KO) responded to 4a-PDD (3 mM; agonist of TRPV4). All cells responded to ionomycin (1 mM). (D) Ca 2+ responses of two representative WT cells from (C) (arrows; upper panels). One cell responded to both TRPV3 and TRPV4 agonists whereas the other one only responded to the V3 agonist cocktail. (E) Ca 2+ responses of two representative V3 KO cells from (C) (arrows; lower panels). One cell responded to the TRPV4 agonist (cell 2); neither cell responded significantly (<0.1 fura-2 ratio) to the V3 agonist cocktail. Schneider et al., 2008) . TGF-a is expressed in both basal (proliferating) and suprabasal (differentiating) layers of epidermis and in the inner root sheath of the hair follicle (Coffey et al., 1987; Luetteke et al., 1993; Mann et al., 1993; Schneider et al., 2008) . Although most highly expressed in the basal layer, suprabasal keratinocytes also express EGFR (Luetteke et al., 1993; Mann et al., 1993; Schneider et al., 2008) . Although induction of differentiation dramatically increases the production of TGF-a/ EGF (Denning et al., 2000) , these same growth factors promote terminal differentiation (Wakita and Takigawa, 1999) . Previous studies suggest that TGF-a/EGF regulate keratinocyte terminal differentiation likely in a Ca 2+ -dependent manner (Denning et al., 2000; Sakai et al., 1994) . Intracellular Ca 2+ regulates both expression and shedding from the membrane-tethered precursors of EGFR ligands (Denning et al., 2000; Horiuchi et al., 2007) . Ca 2+ ionophores are sufficient to induce both production and release of TGF-a (Horiuchi et al., 2007; Pandiella and Massague, 1991) . The Ca 2+ influx pathway under physiological conditions, however, has not been identified.
The cornified cell envelope (CE) is a protein-lipid layer that replaces the plasma membrane of terminally differentiated keratinocytes (corneocytes) and is crucial for the stratum corneum epidermal barrier (Lorand and Graham, 2003) . The CE is a complex layer of lipids attached to a layer of crosslinked proteins. The transglutaminases (TGases) primarily form 3-(g-glutamyl) lysine isopeptide bonds between proteins, and their activities strongly depend on intracellular Ca 2+ levels (Lorand and Graham, 2003) . EGF can acutely activate TGases to induce CE formation and keratinocyte terminal differentiation (Lorand and Graham, 2003) . Cornification-promoting cellular cues may activate an unidentified Ca 2+ influx channel to induce TGase activity and subsequent CE formation.
Transient receptor potential (TRP) proteins are a large family of Ca 2+ -permeable channels with diverse functions (Montell, 2005; Nilius et al., 2007; Ramsey et al., 2006) . Among these, TRPV3 and TRPV4 are functionally expressed in keratinocytes (Chung et al., 2004; Moqrich et al., 2005) . These channels detect ambient temperature changes and are activated by various plant-derived and synthetic compounds (Moqrich et al., 2005; Xu et al., 2006) . In this study, we find that TRPV3-deficient mice exhibit hair phenotypes similar to wa1 and wa2. Molecular and biochemical analyses of TRPV3-deficient mice and isolated keratinocytes reveal defective TGF-a/EGFR signaling. We propose that TRPV3 is a Ca 2+ entry pathway tightly associated with the TGF-a/EGFR signaling complex orchestrating keratinocyte terminal differentiation.
RESULTS
Whole-Animal and Keratinocyte-Specific Disruption of Mouse Trpv3 Gene Using a recombineering method, we inserted two loxP sites to flank exon 13 of mouse Trpv3 (see Figure S1 available online) and obtained mice with homozygous floxed (fl) alleles. To investigate the in vivo function(s) of TRPV3, we generated TRPV3 global knockout (KO) using Sox2-Cre transgenic mice (details described in Experimental Procedures). To elucidate the role of TRPV3 in the skin, we also bred the fl/fl animals to mice harboring a K14-Cre recombinase transgene, which efficiently expresses Cre throughout the epidermis by embryonic day 15.5 (E15.5) (Wang et al., 1997) . Mouse genotypes from both TRPV3 global KO (Trpv3 À/À ; abbreviated as V3 KO) and K14-specific conditional KO (V3 fl/fl: K14 Cre; abbreviated as V3 cKO) were confirmed by PCR ( Figure 1A , also see Figure S1 ). No TRPV3 full-length transcript was detected from V3 KO skin tissues using RT-PCR analysis ( Figure S1 ). No full-length TRPV3 protein was detected by western blot in V3 KO skin lysates ( Figure 1B ) or cultured primary keratinocytes (data not shown). Thus, the mice generated completely lack TRPV3 in their skin. ] i increases were evoked by 4a-PDD (3 mM), an agonist of TRPV4 (Watanabe et al., 2002) that is also expressed in keratinocytes. Similar results were (F-J) TRPV3-like currents were completely absent in V3 KO primary keratinocytes. (F) Application of the V3 agonist cocktail (200 mM 2-APB + 500 mM Carvacrol) to WT primary keratinocytes induced TRPV3-like (I TRPV3 ) currents. Whole-cell currents were generated in response to 400 ms voltage ramps from À100 to +100 mV, applied every 4 s. Holding potential = 0 mV. Each symbol represents the current amplitude at +80 mV (red triangles) and À80 mV (black circles), respectively. Blue dashed line = zero current. (G) Representative ramp current of I TRPV3 . I-V relations were recorded at time points noted in (H) (filled circles). I TRPV3 was doubly rectifying and reversed near 0 mV. Ruthenium red (RuR; 5 mM) selectively blocked inward I TRPV3 with significant augmentation at very positive potentials. (H and I) No significant currents were induced by the V3 agonist cocktail in V3 KO keratinocytes. (J) Average I TRPV3 current densities elicited by the V3 agonist cocktail alone or with the coapplication of RuR (5 mM). At À80 mV, inward I TRPV3 of WT keratinocytes were À45 ± 13 pA/pF (n = 11) and À0.3 ± 0.3 pA/pF (n = 11) in the absence or presence of RuR, respectively. At +80 mV, outward I TRPV3 of V3 +/+ keratinocytes were 62 ± 21 pA/pF (n = 11) and 70 ± 21 pA/pF (n = 11) in the absence or presence of RuR, respectively. For V3 KO keratinocytes, no significant inward or outward I TRPV3 was detected: À0.3 ±± 0.3 pA/pF at À80mV (n = 8) and 0.8 ± 0.5 pA/pF at +80 mV (n = 8), respectively. Data are presented as the mean ± standard error of the mean (SEM). See also Figure S1 . (Chung et al., 2004; Hu et al., 2004; Ramsey et al., 2006; Xu et al., 2006) , almost completely (>99%) inhibited agonist-activated inward I TRPV3 . Similar RuRsensitive I TRPV3 was also evoked by other TRPV3 agonists (200 mM 2-APB + heat or 200 mM 2-APB + 5 mM Camphor) in the same cells. In V3 KO keratinocytes, in contrast, no significant current was evoked by the V3 agonist cocktail ( Figures 1H, 1I , and 1J). Similar results were obtained in keratinocytes from V3 cKO mice.
TRPV3-Deficient Mice Exhibit Curly Whiskers and Wavy Hair
Although previous animal studies identified TRPV3 0 s function in temperature sensation (Moqrich et al., 2005) , the most obvious phenotypic changes we observed from our V3 KO mice are abnormalities in skin, hair, and whiskers. In contrast with littermate controls (WT and heterozygotes [Hets] ), most whiskers of V3 KO mice were characteristically curled or hooked (Figure S2) . The curly morphology of whiskers was apparent at birth ( Figure S2 ); newborn V3 KO mice could be identified based on whisker morphology alone. Keratinocyte-specific V3 cKO mice exhibited similar curly whiskers (Figures 2A and 2B ), suggesting that the phenotype was caused by specific V3 deficiency in keratinocytes. Whisker curliness grew more obvious with age ( Figure 2B and Figure S2 ). Both the dorsal and ventral coat fur, as well as the tail hair, of V3 KO and cKO mice were wavy ( Figure 2B and Figure S2 ) beginning 1 week after birth but was most apparent once the hair was well formed ($3-4 weeks postnatal), gradually reducing with age. In contrast to a previous study reporting abnormality of ventral hairs in a subset of V3 KO mice (Moqrich et al., 2005) , curly whiskers and wavy hair were present throughout the coat at all ages with 100% penetrance for both V3 KO and cKO mice that we have generated, as well as the V3 KO mice reported by Moqrich et al. (H.L., S.M.H., and M.J.C., unpublished data). In comparison, TRPV1 KO mice hair shape and distribution are normal ( Figure S2 ). Consistent with the expression of TRPV3 in follicular keratinocytes of mouse (Peier et al., 2002) and human (Xu et al., 2002) , the wavy phenotype correlated with V3 deficiency in keratinocytes.
Skin contains many cell types, including sensory nerves. However, as the K14 promoter drives the expression of Cre recombinase specifically in all keratinocytes (both follicular and interfollicular) in the skin (Coulombe et al., 1989) , the results obtained from V3 cKO, V3 fl/fl: K14 Cre mice suggested that the defect in hair morphogenesis was due to the lack of TRPV3 expression in keratinocytes in a cell-autonomous manner. Both hair and whisker phenotypes were independent of pigmentation of the hair and genetic background, as black-coated (C57BL/6) backcrossed (>6 generations) V3 KO mice displayed phenotypes similar to those of mice with mixed genetic background (BL6 and 129sv) ( Figure S2 ). V3 KO pups were born with the expected Mendelian ratio, and body weight was comparable to control mice ( Figure S2 ).
In histological examinations of skin from the mid-dorsal region of mice of different ages, we found that a subset of hair follicles exhibited an obvious but gentle curvature ( Figure S2 ). In Haematoxylin & Eosin (H&E) stained skin sections from control mice (P4), hair follicle shafts were parallel and posed roughly at a 45 angle to the subcutaneous muscle layer ( Figure 2C ). In contrast, individual hair follicles of V3 cKO mice were, in many cases, gently curved and pointed in different directions with variable Figure S2 .
angles ( Figure 2C ). Several hair follicles even grew horizontally to the subcutaneous muscle layer. Similar follicular derangement was obvious for V3 KO mice ( Figure S2 ). Notably, similar alterations in hair follicle morphology have been reported in EGFRdeficient mice (Threadgill et al., 1995) . These results suggest that the wavy hair phenotype of V3 KO mice was due to a defect in follicle formation, and that mouse TRPV3 was required for normal morphogenesis of hair and whiskers. In addition to follicular abnormalities, V3 KO and cKO mice also exhibited abnormalities in the epidermal stratum corneum (Figures 2C and 2D ; Figure S2 ; details see below). The hair cycle, however, was not significantly altered ( Figure S2 ).
Defective TGF-a/EGFR Signaling in TRPV3-Deficient Mice
The hair and whisker phenotype of V3 KO mice resembled largely those of wa1 and wa2 mice, as well as other mouse mutations with reduced expression/release/activity in TGF-a and/or EGFR (Ballaro et al., 2005; Du et al., 2004; Luetteke et al., 1993 Luetteke et al., , 1994 Mann et al., 1993; Miettinen et al., 1995; Murillas et al., 1995; Peschon et al., 1998; Schneider et al., 2008; Sibilia and Wagner, 1995; Threadgill et al., 1995 ) (see Figure S3 ). Thus we investigated whether TGF-a and/or EGFR signaling was altered in V3 KO mice. Real-time semiquantitative PCR (q-PCR) analysis of the skin of V3 KO pups revealed that the mRNA expression level of TGF-a was half that of WT (P4; Figure 3A) . TGF-a mRNA levels of newborn (P0) V3 KO animals, though significantly less than those of the P4 mice, were comparable to those of the littermate controls (P0). Expression (mRNA) levels of several other EGFR ligands and EGFR ( Figure S3 ), however, were not significantly altered in the skin of V3 KO mice. These results suggest that TRPV3 affects the expression level of TGF-a in postnatal skin in vivo. Both expression and proteolytic shedding of the membranetethered TGF-a are known to be Ca 2+ dependent (Denning et al., 2000; Horiuchi et al., 2007) . We used an ELISA assay optimized for human TGF-a to investigate the role of TRPV3 in TGF-a shedding/release. In the presence of TRPV3 agonist cocktail (100 mM 2-APB + 250 mM Carvacrol; 30 min), normal human epidermal keratinocytes (NHEK) released more than twice the amount of TGF-a into the culture medium. This is comparable to the effect of PMA, a stimulus well known to induce release and expression of TGF-a ( Figure 3B ). ADAM17, the principal sheddase required for TGF-a release (Peschon et al., 1998) , was required for V3 agonist-induced TGF-a release/shedding ( Figure 3C ). As the level of TGF-a was reduced in V3 KO skin, one would expect that its activated receptor, phosphorylated EGFR (P-EGFR), might also be reduced. By immunoblot analysis of P-EGFR in skin lysates of V3 KO skin, EGFR activity was only about one-third of that of WT controls ( Figures 3D and 3E ). Interestingly, the expression level of total EGFR was slightly but significantly increased in V3 KO skin (1.8-± 0.3-fold, n = 6), so that the ratio of P-EGFR/total EGFR was about 5-fold less (0.20 ± 0.03, n = 4) in V3 KO skin. This level of the reduction was comparable to those of the hypofunctional EGFR mutations causing ''wavy'' phenotypes (Du et al., 2004) . Consistent with biochemical results, EGFR staining was more prominent in V3 KO frozen skin sections ( Figure S3 ), whereas P-EGFR immunostaining was weaker. These results are consistent with dramatically reduced EGFR activity in V3 KO mice and suggest that the level of total EGFR was increased as a consequence of reduced activity, tyrosine phosphorylation-dependent endocytic degradation (Schneider et al., 2008) , or other compensatory mechanisms. The reduction of EGFR activity in V3 KO mice was probably due to the loss of the TRPV3 channel activity, as activation of TRPV3 in cultured keratinocytes using TRPV3 agonists resulted in increases in both TGF-a release ( Figures 3B and 3C ) and EGFR activity ( Figure 3F and Figure S3) . Notably, the TRPV3-induced increase of EGFR activity in keratinocytes was abolished by a neutralizing TGF-a antibody or ADAM17 sheddase inhibitor ( Figures 3F and 3G) , suggesting that activation of TRPV3 led to an increase in TGF-a release and subsequent EGFR activation.
Regulation of TRPV3 Channel Activity by TGF-a/EGFR Signaling Several in vitro studies provided evidence that TRP channels are regulated by members of the receptor tyrosine kinase (RTK) family (Li et al., 1999; Ramsey et al., 2006) . We hypothesized that TRPV3 channel activity could also be upregulated by EGFR signaling. In serum-starved primary keratinocytes cultured in the absence of TGF-a, Ca 2+ responses could be induced by a high concentration (100 mM 2-APB + 250 mM Carvacrol), but not by a lower concentration (50 mM 2-APB + 125 mM Carvacrol), of V3 agonist cocktail ( Figures 4A and 4C ). In the presence of TGF-a (100 ng/ml for 3-5 hr), however, large [Ca 2+ ] i increases were recorded even with a low concentration (50 mM 2-APB + 125 mM Carvacrol) of V3 agonist cocktail; responses to a high concentration of V3 agonists were comparable to those without TGF-a treatment ( Figures 4B and 4C) . Similar results were seen with EGF (100 ng/ml) pretreatment ( Figure S4 ). TGF-a/EGF treatment altered the sensitivity of TRPV3 in keratinocytes to V3 agonists, suggesting that the increased activity was at least partially mediated by increased channel gating, rather than the expression or surface expression of TRPV3 proteins. Consistent with this interpretation, the temperature-induced response (from 22 C to 41 C) was also significantly larger in TGF-a-treated keratinocytes ( Figure S4 ). The sensitizing effect of TGF-a was most likely mediated by EGFR, as an EGFR inhibitor (AG1478) or shRNA knockdown of EGFR expression ( Figure S4 ) completely or largely eliminated its potentiation ( Figures 4D and 4E ). Because inhibitors of PLC (U73122) and ERK (PD98059) completely or partially blocked potentiation ( Figure 4D ), these pathways may underlie the sensitizing effect downstream of EGFR receptor activation. In support of this finding, shRNA knockdown of PLC-g1 expression ( Figure S4 ) significantly decreased the sensitizing effect of TGF-a ( Figure 4E ). Consistent with our [Ca 2+ ] i measurements, I TRPV3 exhibited a similar dependence on TGF-a ( Figure 4F) .
The results presented so far raise the possibility that TRPV3 and EGFR might be in a signaling complex. To test this hypothesis, coimmunoprecipitation (co-IP) experiments were first performed in a heterologous expression system. In cells transfected with TRPV3, either alone or together with EGFR, both endogenous (data not shown) and overexpressed EGFR ( Figure S4 ) were found to co-IP with TRPV3. Next, we confirmed this finding (D) Immunoblotting analysis of phosphorylated (active; P-EGFR) and total EGFR expression levels of WT and V3 KO skin lysates. Compared to WT mice, the level of P-EGFR was significantly decreased in V3 KO skin lysates. In contrast, the expression level of total EGFR was slightly but significantly increased in V3 KO skin lysates. (E) Statistical analyses of EGFR and P-EGFR expression levels. (F and G) EGFR activity (P-EGFR) was enhanced by V3 agonist cocktail (100 mM 2-APB + 250 mM Carvacrol) for 30 min. The basal activation of EGFR was induced by a minimal concentration of EGF (0.5 ng/ml). The enhancement was abolished in the presence of BB2116 (20 mM) or a neutralizing antibody against TGF-a (1 mg/ml). Data in (A), (B), (C), (E), and (F) are presented as the mean ± SEM. See also Figure S3 . in keratinocytes ( Figure 4G ) using skin tissues from TRPV3-YFP transgenic mice (Huang et al., 2008) . These results suggest that EGFR can directly or indirectly associate with TRPV3 in both heterologous and native systems. Consistent with the close association of these molecules, we found that activation of EGFR with TGF-a resulted in tyrosine phosphorylation of TRPV3 ( Figure 4H ).
Altered Keratinocyte Differentiation in TRPV3-Deficient Mice
EGFR signaling is known to have at least two distinct functions in epidermis (Schneider et al., 2008) . In the basal layer, TGF-a/ EGFR signaling promotes keratinocyte proliferation (Schneider et al., 2008) . The function of EGFR signaling in suprabasal cells is to promote late terminal differentiation (Ballaro et al., 2005; Dlugosz et al., 1994; Peus et al., 1997; Wakita and Takigawa, 1999) . Whereas proliferating keratinocytes in the basal layer express structural keratins K5/K14, differentiating keratinocytes express the structural keratins K1/K10 (Byrne et al., 2003) . As keratinocytes move closer to the skin surface, expression of K1/K10 declines and loricrin expression increases (Byrne et al., 2003) , as they undergo cornification. Consistent with previous studies (Wakita and Takigawa, 1999) , we observed that EGF significantly reduced the expression of the early differentiation marker K1 in suspended keratinocytes ( Figure S5) . We reasoned that a reduced rate of autonomous EGFR-dependent proliferation or terminal differentiation would accelerate keratinocyte early differentiation in V3 KO cells. Compared to WT skin sections, V3 KO epidermis exhibited a >2-fold increase in the thickness of the K1-positive layer ( Figure 5A ), whereas cell sizes and densities were normal ( Figure S5 ). Similar results were reported in transgenic mice with defective TGF-a/EGFR signaling or keratinocytes cultured in the presence of EGFR inhibitors (Ballaro et al., 2005; Peus et al., 1997) . No significant change was observed in the K14 layer of V3 KO epidermis ( Figure 5B ). Loricrin expression was relatively less elevated in V3 KO epidermis ( Figure 5C ). Consistent with the increased early differentiation in V3 KO epidermis, thickness of K10 (interaction partner of K1) layer also increased in V3 KO animals (Figure 5D) . Finally, V3 cKO animals exhibited similar alterations in keratinocyte differentiation ( Figure 5E) . and granular layers) was elevated in V3 KO skin sections. Integrin a6 antibody labeled the basement membrane, the boundary between epidermis and dermis. DAPI is a nuclear marker. The K1-positive layer was 2-fold thicker in V3 KO epidermis (quantified in the A 0 panel).
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(B and B 0 ) Normal immunofluorescence of keratin protein 14 (K14; a keratinocyte structural protein and a marker for the proliferating basal layer).
(C and C 0 ) Slightly but significantly elevated loricrin (a marker for the differentiating granular layer) immunofluorescence in V3 KO epidermis.
(D and D 0 ) Elevated keratin protein 10 (K10; a keratin protein associated with K1 immunofluorescence in V3 KO epidermis.
(E and E 0 ) Elevated K1 immunofluorescence in V3 cKO epidermis.
Data in (A 0 )-(E 0 ) are presented as the mean ± SEM. See also Figure S5 . Ca 2+ is an important regulator of keratinocyte differentiation both in vitro and in vivo (Yuspa et al., 1989) . We next examined Ca
2+
-dependent keratinocyte differentiation in vitro using a well-established Ca 2+ switch protocol. In these experiments, epidermal basal cells were selectively cultured in 0.05 mM Ca 2+ medium and terminal differentiation was induced by raising [Ca 2+ ] o to 0.2-1.4 mM (Yuspa et al., 1989) . Compared to WT cells, more loricrin was expressed in cultured V3 KO keratinocytes after induction of differentiation ( Figure S5 ). Collectively, these results suggest a role of TRPV3 in keratinocyte differentiation both in vitro and in vivo. 
Defective Epidermal Barrier Function and TGase Activity in TRPV3-Deficient Mice
In addition to hair abnormalities, the skin of newborn V3 KO and cKO mice was red in color (erythroderma), dry, and scaly ( Figures 6A and 6B ), resembling the skin phenotype of mice with defective barrier formation (Koch et al., 2000; Sevilla et al., 2007) . Before hair penetration (P0-P3), the skin of V3 KO mice was rougher and shinier than that of WT. To measure skin barrier integrity, we used toluidine blue exclusion. In newborn (P0) V3 WT, KO, and E17 WT mice, dye was almost completely excluded, indicating normal maturation of the skin barrier. In E17 V3 KO embryos, however, dye permeability was significant, particularly in ventral areas ( Figure 6C ). EGF is known to increase the thickness of stratum corneum (Ponec et al., 1997) , and consistent with a role for TRPV3 in barrier formation, the stratum corneum layer of V3 KO ( Figure S2 ) and cKO ( Figures  2C and 2D ) mice was significantly thinner and more compact than WT littermates. We next examined the morphology of the mature CE. Mature CE in WT skin was symmetrical and smooth, whereas immature CE was irregular and fragile. The density of mature CE in V3 KO ( Figure S6 ) and cKO mice ( Figures 6D and  6E ) was only 15%-18% of that in WT mice.
Multiple mechanisms might lead to defective CE formation. TGases are a family of enzymes that crosslink proteins essential for CE formation (Lorand and Graham, 2003) . Among them, TGase1 and TGase3 are expressed in the epidermis and are regulated by intracellular Ca 2+ (Lorand and Graham, 2003) . One possibility is that the activity of TGases was reduced in V3 KO mice. EGF or TGF-a is known to dramatically increase the activity of TGases and CE formation in cultured keratinocytes in suspension, which presumably mimics the conditions of suprabasal keratinocytes (Wakita and Takigawa, 1999) . We found that the activity of TGases (Koch et al., 2000; Raghunath et al., 1998) was significantly lower in both newborn (P1) and P4 V3 cKO epidermis ( Figure 6F ) but not in age-matched V1 and V4 KO epidermis ( Figure S6 ). The expression level of TGase1, however, was comparable for WT and V3 cKO ( Figure 6G ). When TGase activity was measured in cultured keratinocytes, TGase activity was abnormally low in both WT and V3 KO keratinocytes ( Figures 6H and 6I) . Application of V3 agonist cocktail dramatically increased TGase activity (>10-fold) in WT but not V3 KO cells. Application of V1 and V4 agonists resulted in either no change or a slight increase in TGase activity in WT keratinocytes ( Figure S6 ). These results suggest that activation of TRPV3 increased intracellular [Ca 2+ ], TGase activity, and subsequent CE formation in the epidermis.
DISCUSSION
Intracellular Ca 2+ regulates both the production and the release of EGFR ligands (Denning et al., 2000; Dlugosz et al., 1994) . As TGF-a production/release is an autoinduction process (Coffey et al., 1987) , the reduced production of TGF-a might result from reduced EGFR activity. The positive feedback loop (Figure 7 ) in which TGF-a/EGFR activation potentiates TRPV3-mediated Ca 2+ entry, which in turn potentiates TGF-a/EGFR signaling, may provide an explanation for its unique property of autoinduction (Coffey et al., 1987) . Ca 2+ -induced differentiation dramatically increases TGF-a production, suggesting a nonproliferative role of the TGF-a/EGFR signaling axis (Denning et al., 2000) . On the other hand, EGF/TGF-a itself is known to promote late terminal differentiation both in vitro and in vivo by dramatically increasing TGase activity and CE formation while suppressing the expression of K10 (Dlugosz et al., 1994; Wakita and Takigawa, 1999) . Thus, for suprabasal cells, the function of EGFR signaling is to promote late terminal differentiation (Wakita and Takigawa, 1999) . The primary defect in V3 KO mice is late terminal differentiation but not proliferation. Thus, the feedforward mechanism described above may contribute to the process of late terminal differentiation. It is still not clear how TRPV3 is activated to trigger or promote late terminal differentiation. Temperatures in the range of 31 C-39 C activate TRPV3 in heterologous expression systems (Ramsey et al., 2006) . Thus temperature may be the primary activator for keratinocyte TRPV3. Consistent with this notion, temperature is known to affect the barrier function and modulate the effect of EGF/TGF-a on keratinocyte differentiation (Denda et al., 2007; Ponec et al., 1997) . At skin temperatures in vivo ($32 C), TRPV3 is constitutively but weakly active. Thus release of TGF-a may increase the activity of weakly constitutively active TRPV3.
We provide evidence that TRPV3 and TGF-a/EGFR are in the same signaling complex regulating epidermal homeostasis. Whereas loss-of-function in TGF-a/EGFR leads to ''wavy hair'' (Luetteke et al., 1993 (Luetteke et al., , 1994 Mann et al., 1993; Schneider et al., 2008; Sibilia and Wagner, 1995; Threadgill et al., 1995) , elevated TGF-a/EGFR activities cause a ''hairless'' phenotype (Ferby et al., 2006; Schneider et al., 2008; Wang et al., 2006) . Interestingly, whereas our V3 KO mice exhibit ''wavy hair,'' mice carrying a gain-of-function mutation in TRPV3 are hairless EGFR is the prototype of the RTK family. EGFR signaling is necessary for proper development and tissue homeostasis whereas its dysregulation rapidly results in defects in cellular proliferation and differentiation. The consequences of its malfunction are abnormal hair follicle morphogenesis, impaired would healing, and tumorigenesis (Schneider et al., 2008) . We have identified another key element in this important signaling pathway, the TRPV3 channel. Our studies not only provide the first in vivo evidence in mammals for the close interaction of RTK and TRP channels but also suggest that TRPV3 can be a novel target for hair growth and removal agents as well as in the treatment of skin cancers or other dermatological diseases.
EXPERIMENTAL PROCEDURES

Conditional and Global Disruption of Trpv3 in Mice
Mouse Trpv3 was disrupted either globally or in a keratinocytes-specific manner (see Extended Experimental Procedures in the Supplemental Information).
Real-Time Semiquantitative PCR
After a small piece of back skin was dissolved in TRIzol (Invitrogen, Carlsbad, CA, USA), mRNA was purified using RNeasy columns (QIAGEN Inc., Valencia, CA, USA). First-strand cDNA was synthesized using Superscript III RT (Invitrogen) and utilized for Semiquantitative PCR based on intron-spanning primers. A Bio-Rad iQ iCycler was used to measure the expression level of transcripts. The primer sequences are provided in the Extended Experimental Procedures.
Preparation and Culture of Mouse Keratinocytes
Mice (P0-P2) were sacrificed and soaked in 10% povidone-iodine for 5 min. After rinsing in 70% ethanol multiple times, the skin was removed and placed in a Petri dish containing PBS solution with 0.25% trypsin (Invitrogen) for incubating at 4 C overnight. Epidermis was then separated from the subcutaneous tissues. Vortexing dissociated cells and keratinocytes were first plated in a high [Ca 2+ ] o (1.4 mM) minimal essential medium (MEM; GIBCO), which was replaced with a low [Ca 2+ ] o (0.05 mM; differentiation-restricted) medium after 6 hr. The keratinocytes were then cultured in MEM containing 8% Chelex-treated (Bio-Rad) FBS with the final [Ca 2+ ] adjusted to 0.05 mM. Suspension cultures were on polyhydroxyethylmethacrylate (poly-HEMA)-coated plates as described previously (Wakita and Takigawa, 1999) .
NHEK Cell Culture
Normal human epidermal keratinocytes were obtained from Invitrogen and cultured in EpiLife Medium supplemented with Human Keratinocyte Growth Supplement (Invitrogen).
Immunoblotting and Immunoprecipitation
Back skin lysates for the immunodetection of EGFR and P-EGFR were prepared as follows: a small piece of back skin was lysed on ice for 30 min using 1 ml of lysis buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, 0.25% sodium deoxycholate, and 13 protease inhibitor cocktail). Immuoprecipitation and immuoblotting were then performed using skin lysates as described in the Extended Experimental Procedures.
Histology and Immunostaining
Tissues were fixed for 3 hr with 4% paraformaldehyde (PFA) at 4 C, embedded in OCT or paraffin. Sections ($4 mm) of paraffin-embedded tissues were stained with hematoxylin and eosin (H&E). Immunohistochemistry was performed on cryostat sections ($10 mm) using antibody dilutions described in the Extended Experimental Procedures.
Dye Exclusion Assays
Toluidine blue staining of mouse embryos and newborn pups was performed as described in the Extended Experimental Procedures.
In Vivo and In Vitro Transglutaminase Activity Assay Detection of TGase activity in skin sections (in vivo) and cultured keratinocytes (in vitro) used the amine donor substrate monodansylcadaverine (Molecular Probes) as described in the Extended Experimental Procedures.
Analysis of Cornified Envelopes
A piece of back skin (P4) was isolated and treated as described previously (Koch et al., 2000) . Briefly, CEs were prepared by boiling skin for 30-60 min in a buffer consisting of 20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM DTT, and 2% SDS. After centrifugation (5,000 g), CEs were washed twice at room temperature with a buffer consisting of 20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM DTT, and 0.2% SDS. The density of CE was manually determined using a hemacytometer.
TGF-a ELISA
The medium of near confluent NHEK keratinocytes was harvested for TGF-a measurements using an ELISA kit for human TGF-a (Calbiochem).
Electrophysiology
Whole-cell recordings were performed in primary keratinocytes. Details of recording conditions are described in the Extended Experimental Procedures.
Ca 2+ Imaging
Mouse and NHEK primary keratinocytes were loaded with 5 mM Fura-2 AM in culture medium at 37 C for 60 min. Cells were then washed in modified Tyrode's solution for 10-30 min. Fluorescence at different excitation wavelengths was recorded on an EasyRatioPro system (Photon Technology International, Birmingham, NJ, USA). Fura-2 ratios (F340/F380) recorded changes in [Ca 2+ ] i upon stimulation. Ionomycin (1 mM) was added at the conclusion of all experiments to induce a maximal response for comparison.
Data Analysis
Data are presented as the mean ± standard error of the mean (SEM). Statistical comparisons were made using analysis of variance (ANOVA). A p value < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and six figures and can be found with this article online at doi:10.1016/j.cell. 2010.03.013.
